Bicycle Therapeutics Plc - ADR

Bicycle Therapeutics Plc - ADR

BCYC

Get informed when a big investor buys or sells

+ Follow
Market Cap$325.46M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Bicycle Therapeutics Plc - ADRBicycle Therapeutics Plc - ADR-1.5--40%--
$11.25

Target Price by Analysts

167.9% upsideBicycle Therapeutics Plc Target Price DetailsTarget Price
$-2.25

Current Fair Value

153.7% downside

Overvalued by 153.7% based on the discounted cash flow analysis.

Share Statistics

Market cap$325.46 Million
Enterprise Value$-217,344,631.00
Dividend Yield$- (-)
Earnings per Share$-3.16
Beta1.56
Outstanding Shares69,683,471

Return

Return on Equity-39.51%ROE
Return on Assets-33.57%
Return on Invested Capital-39.97%

Valuation & Multiples

P/E Ratio-1.49P/E Ratio
PEG-1276.77PEG
Price to Sales-Price to Sales
Price to Book Ratio0.6Price to Book Ratio
Enterprise Value to Revenue-3.42
Enterprise Value to EBIT0.9
Enterprise Value to Net Income0
Total Debt to Enterprise-0.08
Debt to Equity0.03Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
May 7, 2026
EPS Estimate
$-0.62
Average shareholder expectation
Revenue Estimate
$7.50 M
Average shareholder expectation

Next Earnings Call

Expected Date
August 14, 2026
EPS Estimate
$-0.58
Average shareholder expectation
Revenue Estimate
$4.35 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio11.3333▲ 1096.14%
Total Calls30,600▼ 90.69%
Total Puts346,800▲ 183.80%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %54.07%▼ 2.45%
Total Invested$173.59M▼ 37.48%
Investors Holding102▼ 13.00%

ESG Score

No data

About Bicycle Therapeutics Plc

CEO: Kevin Lee